$BNGO continue on its path to break the resistanceI am still convinced that #BNGO is still on the path to break the resistance soon.
May be a little correction to bring the RSI at the bottom before the push upward.
It's about time.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.3104 USD
−232.49 M USD
36.12 M USD
101.47 M
About Bionano Genomics, Inc.
Sector
Industry
CEO
Robert Erik Holmlin
Website
Headquarters
San Diego
Founded
2003
FIGI
BBG001KWWRS9
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
$BINGO can this be the bottom?#BINGO it's showing a hammer candle, positive sign that we possibly reached the bottom.
Also, we can see a trend line that can be broken.
If and once that happens we can see a change of trend (finally) for #BIONANO and see an upward trend.
Need to check if today's candle closes with a hammer candleHello traders!
If you "Follow" us, you can always get new information quickly.
Please also click “Boost”.
Have a good day.
-------------------------------------
(BNGO 1M chart)
It is renewing its low point by falling below the HA-Low indicator point of 6.49.
Touching the HA-Low indicator point
BNGO Pharma Huge FailBNGO has shown very negative performance, as this chart will demonstrate.
Using the Cloud Trend Pattern Method has not yet shown an entry position, however this could soon revert.
Keeping this one on my watch list for a possible +300% Upside, but as all Pharma will need a Catalyst.
As always please
BNGO Trading Strategy: Market Analysis and Profit TargetsStrong Support: BNGO presents a buying opportunity.
Market Structure: The weekly chart shows the completion of impulse waves 1, 2, 3, 4, and 5, and now we are entering correction waves ABCD.
Stop Loss: Set at the Fibonacci extension of 127.2 (equivalent to $1.10).
Profit Targets: Fibonacci Retrac
BNGO Trading Strategy: Market Analysis and Profit Targets PART 2BNGO offers a strong buying opportunity with an anticipated price surge.
Market Structure: The 2W chart reveals a completed bullish butterfly pattern XABCD.
The yellow circle highlights the three instances of price explosions.
Fibonacci Retracements:
* X to A at 0.786 for point B
* A to B ranging
BNGO 15min BNGO 15min trendline, breakout bearish pennant w/measured move $0.5954. $2.31 is next resistance and target price before continuation of correction. Correction to $0.47-$0.55. Retracement back to $2.31.
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome a
BNGO Down 90% in 1 YearBionaro Stock is down +-90% in 1 Year.
Clearly a mismanaged Company from the market sentiment valuation.
Can they give the market a surprise similar to other MEDICAL type Genome Stocks?
To date there has been little information released on any marketing or social media, so we will have to wait for n
BNGO Technical Analysis Bngo appears to be nearing the end of it’s sequence. Last time this happened, it squeezed significantly. I see gaps going to around 11.50. There has also been some recent insider buying which hasn’t happened since before the last time it squeezed. I am seeing a break within the next few weeks to 2 t
KalaGhazi | Bionano Genomics, Inc. Bionano Genomics, Inc.
Great upside from this stock!
Don't miss out
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BNGO is 0.1950 USD — it has decreased by −2.74% in the past 24 hours. Watch Bionano Genomics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bionano Genomics, Inc. stocks are traded under the ticker BNGO.
BNGO stock has fallen by −17.58% compared to the previous week, the month change is a −15.22% fall, over the last year Bionano Genomics, Inc. has showed a −88.25% decrease.
We've gathered analysts' opinions on Bionano Genomics, Inc. future price: according to them, BNGO price has a max estimate of 2.80 USD and a min estimate of 1.00 USD. Watch BNGO chart and read a more detailed Bionano Genomics, Inc. stock forecast: see what analysts think of Bionano Genomics, Inc. and suggest that you do with its stocks.
BNGO reached its all-time high on Feb 16, 2021 with the price of 156.9000 USD, and its all-time low was 0.2000 USD and was reached on Nov 21, 2024. View more price dynamics on BNGO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BNGO stock is 4.62% volatile and has beta coefficient of 2.73. Track Bionano Genomics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bionano Genomics, Inc. there?
Today Bionano Genomics, Inc. has the market capitalization of 19.89 M, it has decreased by −12.52% over the last week.
Yes, you can track Bionano Genomics, Inc. financials in yearly and quarterly reports right on TradingView.
Bionano Genomics, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
BNGO earnings for the last quarter are −0.52 USD per share, whereas the estimation was −0.20 USD resulting in a −163.26% surprise. The estimated earnings for the next quarter are −0.13 USD per share. See more details about Bionano Genomics, Inc. earnings.
Bionano Genomics, Inc. revenue for the last quarter amounts to 6.07 M USD, despite the estimated figure of 7.76 M USD. In the next quarter, revenue is expected to reach 6.30 M USD.
BNGO net income for the last quarter is −44.25 M USD, while the quarter before that showed −16.22 M USD of net income which accounts for −172.72% change. Track more Bionano Genomics, Inc. financial stats to get the full picture.
No, BNGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 344.00 employees. See our rating of the largest employees — is Bionano Genomics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bionano Genomics, Inc. EBITDA is −80.47 M USD, and current EBITDA margin is −348.10%. See more stats in Bionano Genomics, Inc. financial statements.
Like other stocks, BNGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bionano Genomics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bionano Genomics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bionano Genomics, Inc. stock shows the sell signal. See more of Bionano Genomics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.